One step 2-nitroimidazole active site capping of commercialized compound.
RANKL fragment peptides treat psoriasis with reduced expression of inflammatory cytokines through Toll-like receptor 7/8 (TLR7/8) signaling pathway.
(Update): Anti-CKAP4 Monoclonal Antibody Obtained
A novel technology loosens tight junction of BBB and supports drug transportation into brain.
Repositioning reovirus, which has been developed as an anti-cancer drug.
Useful for gene therapy by minimizing non-homologous end joining (NHEJ) derived Insertions or deletions (Indels)
Selective inhibition of Periostin variant (PN1) by monoclonal antibody
Excellent Vaccine Development/Research Platform
Cell Surface Antigen CD48 as A Novel Molecular Target for Antibody Therapy in Multiple Myeloma
Variant Specific Periostin Neutralization for Diabetic Retinopathy